DK1954288T3 - Amidin-derivater og anvendelse deraf som lægemiddel - Google Patents

Amidin-derivater og anvendelse deraf som lægemiddel

Info

Publication number
DK1954288T3
DK1954288T3 DK06820232.4T DK06820232T DK1954288T3 DK 1954288 T3 DK1954288 T3 DK 1954288T3 DK 06820232 T DK06820232 T DK 06820232T DK 1954288 T3 DK1954288 T3 DK 1954288T3
Authority
DK
Denmark
Prior art keywords
drug
amidine derivatives
amidine
derivatives
Prior art date
Application number
DK06820232.4T
Other languages
English (en)
Inventor
Serge Auvin
Dennis Bigg
De Lassauniere Pierre-Etienne Chabrier
Bernadette Pignol
Original Assignee
Ipsen Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0510751A external-priority patent/FR2892415B1/fr
Priority claimed from FR0601999A external-priority patent/FR2898357B1/fr
Application filed by Ipsen Pharma filed Critical Ipsen Pharma
Application granted granted Critical
Publication of DK1954288T3 publication Critical patent/DK1954288T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C07D279/20—[b, e]-condensed with two six-membered rings with hydrogen atoms directly attached to the ring nitrogen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
DK06820232.4T 2005-10-21 2006-10-18 Amidin-derivater og anvendelse deraf som lægemiddel DK1954288T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0510751A FR2892415B1 (fr) 2005-10-21 2005-10-21 Derives d'amidine et leurs applications a titre de medicament
FR0601999A FR2898357B1 (fr) 2006-03-07 2006-03-07 Derives d'amidine et leurs applications a titre de medicament
PCT/FR2006/002338 WO2007045761A1 (fr) 2005-10-21 2006-10-18 Derives d'amidine et leurs applications a titre de medicament

Publications (1)

Publication Number Publication Date
DK1954288T3 true DK1954288T3 (da) 2012-09-24

Family

ID=37758631

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06820232.4T DK1954288T3 (da) 2005-10-21 2006-10-18 Amidin-derivater og anvendelse deraf som lægemiddel

Country Status (10)

Country Link
US (1) US7659266B2 (da)
EP (1) EP1954288B1 (da)
JP (1) JP5280850B2 (da)
CA (1) CA2626591A1 (da)
DK (1) DK1954288T3 (da)
ES (1) ES2390134T3 (da)
HK (1) HK1124780A1 (da)
PL (1) PL1954288T3 (da)
PT (1) PT1954288E (da)
WO (1) WO2007045761A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1954288B1 (fr) 2005-10-21 2012-08-01 Ipsen Pharma Derives d'amidine et leurs applications a titre de medicament
FR2898274B1 (fr) * 2006-03-07 2008-10-03 Sod Conseils Rech Applic Composition contenant des derives d'amidine ou de carboxamide et des steroides a titre de medicament
JP2010535708A (ja) 2007-08-03 2010-11-25 ビオマリン アイジーエー リミテッド デュシェンヌ型筋ジストロフィーの治療のための薬物併用
GB0715087D0 (en) 2007-08-03 2007-09-12 Summit Corp Plc Drug combinations for the treatment of duchenne muscular dystrophy
GB2467561A (en) * 2009-02-06 2010-08-11 Summit Corp Plc Dual calpain-ROS inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003513092A (ja) * 1999-11-05 2003-04-08 ソシエテ・ド・コンセイユ・ド・ルシエルシエ・エ・ダアツプリカーション・シヤンテイフイツク・（エス．セー．エール．アー．エス） 新規複素環化合物及びその医薬としての使用
FR2863268B1 (fr) * 2003-12-09 2006-02-24 Sod Conseils Rech Applic Nouveaux derives du 2-hydroxytetrahydrofuranne et leur application a titre de medicaments
US7696197B2 (en) * 2004-03-29 2010-04-13 Societe De Conseils De Recherches Et D'applications Scientifiques Use of a phenothiazine derivative for preventing and/or treating hearing loss
EP1954288B1 (fr) 2005-10-21 2012-08-01 Ipsen Pharma Derives d'amidine et leurs applications a titre de medicament

Also Published As

Publication number Publication date
WO2007045761A1 (fr) 2007-04-26
EP1954288A1 (fr) 2008-08-13
JP5280850B2 (ja) 2013-09-04
PT1954288E (pt) 2012-10-03
US20090018120A1 (en) 2009-01-15
ES2390134T3 (es) 2012-11-06
JP2009513577A (ja) 2009-04-02
HK1124780A1 (en) 2009-07-24
CA2626591A1 (fr) 2007-04-26
PL1954288T3 (pl) 2012-12-31
EP1954288B1 (fr) 2012-08-01
US7659266B2 (en) 2010-02-09

Similar Documents

Publication Publication Date Title
DK1894567T3 (da) Ledsagende farmaceutiske midler og anvendelse deraf
IS8578A (is) 3- karbamoýl - 2- pýridón afleiður
NO2014028I1 (no) Empagliflozin og salter derav, og spesielt Empagliflozin
ATE383361T1 (de) Pyrrazolopyrimidinderivate
DK1725553T3 (da) Tetrahydropyridoindolderivater
ATE540935T1 (de) Chinazolinderivate
ATE417830T1 (de) Sulfonylbenzimidazolderivate
DE602005026188D1 (de) Medikamentenspender
ATE415400T1 (de) Pyrazolopyridinderivate
DK1957073T3 (da) Lægemiddel
ATE550315T1 (de) Pestizid-bi-phenyl-amidin-derivate
DK1753764T3 (da) Pyrrolopyridin-derivater
DK2051975T3 (da) Substituerede prolinamider, fremstilling deraf og anvendelse deraf som lægemiddel.
DK1771421T3 (da) N-hydroxyamidderivater og anvendelse deraf
DK1885716T3 (da) Thiazolderivater og anvendelse deraf
DE602006010581D1 (de) 4-phenyl-6-substituierte pyrimidin-2-carbonitrilderivate
DK1757293T3 (da) Bh4-responsiv hyperphenylalaninæmi-medikamenter
ATE485294T1 (de) Azaindol-2-carboxamid-derivate
ATE430142T1 (de) Phenylpiperazin-methanon-derivate
DK1902050T3 (da) Oxazolidinonderivater og anvendelse deraf som antibiotika
ATE527255T1 (de) Aryl-isoxazol-4-yl-imidazol-derivate
DK1971588T3 (da) Tiglien-3-onderivater
ATE404542T1 (de) 4-phenylpyrimidin-2-carbonitrilderivate
DK2918286T3 (da) En farmaceutisk formulering
DK1828137T3 (da) 4-Cycloalkyl-substituerede tetrahydroquinolinderivater og deres anvendelse som medikamenter